Innovation Medical (002173) has long focused on the medical services sector. Its subsidiary, Bo Ling Medical, is a core force in the clinical translation of brain-computer interface (BCI) technology in China. Leveraging its extensive experience in neurological rehabilitation, the company holds a first-mover advantage in BCI device development and clinical applications. Centered on medical services, it covers areas such as neurological rehabilitation and cardiovascular diagnosis and treatment, while advancing BCI technology R&D and clinical translation, with a focus on functional reconstruction for patients with severe neurological injuries. Its Bo Ling BCI-4000 brain-computer product has entered Phase III clinical trials. Utilizing invasive electrodes to capture brain signals, it enables device control through thought, aiding in the rehabilitation of patients with high-level paralysis. It is one of the few domestic BCI companies in the late clinical stages. With the implementation of BCI medical insurance reimbursement policies, the clinical translation process is expected to accelerate. Upon product approval, it is poised to become one of China's first commercially available invasive BCI devices, potentially driving volume and price increases for its neurological rehabilitation business.

Tom Cat (300459) leverages well-known IPs like "Talking Tom Cat" and has built a substantial user base in digital entertainment. In recent years, it has actively explored the convergence of AI and BCI, investigating new immersive interactive scenarios. Its core business involves IP operations, mobile application development, and digital content creation, focusing on casual entertainment and children's education, while also promoting R&D in BCI and AI interactive technologies. It is exploring applications like mind-controlled gaming and immersive entertainment, using non-invasive BCI devices to capture user intent for game control and content interaction, creating a novel "mind-control entertainment" experience. As BCI technology penetrates consumer-level scenarios, the company may leverage its IP strengths to launch mind-controlled interactive products, unlocking commercial potential in entertainment. The integration of AI and BCI technologies is expected to enhance user engagement and monetization capabilities.

Meihao Medical (301363) specializes in the manufacturing of precision medical components, supplying core parts to globally renowned medical device companies. It possesses technical advantages in precision machining and the application of biocompatible materials and has recently entered the BCI industry chain. Its main business includes the R&D, production, and sales of precision medical components and implantable medical device components, covering areas like cardiovascular and neurointervention, while also providing precision structural components for BCI devices. It supplies precision components such as electrode brackets and encapsulation parts for BCI equipment, supporting the hardware manufacturing of both invasive and non-invasive BCI devices, positioning it as a key upstream supplier. As mass production demand for BCI devices grows, orders for precision components are expected to increase steadily. Leveraging its expertise in biocompatible materials, the company can deepen collaborations with BCI firms, opening up new avenues for profit growth.

Yanshan Technology (002195) focuses on brain-like intelligence and artificial intelligence, leveraging university research collaborations to build core competitiveness in neural signal decoding algorithms. It has recently prioritized the practical application of BCI technology. Its main business involves the R&D and application of AI and brain-like intelligence technologies, covering industrial inspection, intelligent monitoring, and neural signal processing, while advancing BCI algorithm development and system integration. By optimizing EEG signal decoding efficiency with AI algorithms, it enhances the precise control capabilities of BCI devices, providing core algorithm support for both invasive and non-invasive BCI equipment, facilitating deployment in clinical and consumer scenarios. As precision requirements for BCI algorithms increase, its brain-like intelligence technology advantages will become more prominent. Algorithm licensing and system integration services are expected to grow, while the fusion of AI and BCI will expand applications across industrial and medical fields.

Star-Net Ruijie (002396), a leading domestic provider of network equipment and solutions, has deep technical expertise in high-speed network transmission and data processing. It has recently actively explored network support solutions for BCI scenarios. Its main business includes network equipment, cloud computing solutions, and data center services, providing efficient and stable network support for enterprise clients, while also offering high-speed data transmission and processing support for BCI devices. It provides high-speed network transmission and data processing solutions for BCI equipment, supporting real-time transmission of brain signals and cloud-based analysis, aiding in remote monitoring and data applications for BCI devices. As data transmission efficiency demands for BCI increase, demand for high-speed network equipment will continue to grow. The company can leverage its technical strengths to deepen collaborations with BCI enterprises, expanding applications in industrial and medical settings.

Aipeng Medical (300753) has extensive experience in pain management and neuromodulation, with substantial expertise in medical device R&D and clinical applications. It is currently exploring BCI applications in post-operative analgesia and neurological rehabilitation. Its main business includes pain management devices, neuromodulation products, and intelligent nursing equipment, focusing on post-operative analgesia and chronic pain treatment, while promoting the implementation of BCI in rehabilitation scenarios. It is investigating the use of BCI in post-operative analgesia and neurological rehabilitation, optimizing treatment plans through BCI technology to achieve precise neuromodulation and improve rehabilitation efficiency. With growing demand for neurological rehabilitation, the application of BCI in medical settings is expected to accelerate. The company may leverage its technical积累 to launch mind-controlled rehabilitation products, expanding the boundaries of medical services.

Entropy Base Technology (301330) leverages its core strengths in biometrics and identity verification, with advantages in security and authentication fields. It has recently focused on BCI applications in identity authentication and secure interaction. Its main business includes biometric devices, identity verification solutions, and security system integration, serving sectors like finance, government, and transportation, while advancing R&D for BCI in secure interaction scenarios. Building on its biometric and identity verification technology, it is developing BCI applications for identity authentication and secure interaction, using EEG signals for accurate identity recognition, opening new possibilities in security scenarios. As demands for accuracy and security in identity authentication increase, the application potential of BCI in the security field is expected to be realized. The company may use its technical advantages to seize market opportunities.

Interest Technology (002925) specializes in intelligent control components and IoT solutions, with technical advantages in precision manufacturing and smart interaction. It has recently provided core components for BCI devices. Its main business includes smart control components, IoT devices, and intelligent manufacturing solutions, serving consumer electronics and smart home sectors, while supplying intelligent control components for BCI equipment. It provides intelligent control components and IoT solutions for BCI devices, supporting smart interaction and data collection, positioning it as a key midstream supplier. As intelligentization demands for BCI devices rise, orders for smart control components are expected to grow steadily. The company can leverage its precision manufacturing strengths to deepen collaborations with BCI firms, expanding applications in consumer and medical-grade scenarios.

Guiyan Platinum (600459) focuses on the R&D and production of precious metal materials, with core competitiveness in key materials like platinum-based alloys, providing essential material support for BCI electrodes. Its main business involves the R&D, production, and sales of precious metal materials, catalytic materials, and functional materials, covering automotive, medical, and electronic sectors, while supplying platinum-based alloy materials for BCI electrodes. It provides key materials like platinum-based alloys for BCI electrodes, enhancing their biocompatibility and signal acquisition stability, establishing it as a core upstream material supplier. As mass production demand for BCI electrodes increases, orders for platinum-based materials are expected to grow. The company can deepen collaborations with BCI enterprises using its material technology advantages, supporting the industry's scaled development.

Y创 Electronic (301099) is involved in automotive-grade chips and power semiconductors, with technical advantages in chip design and manufacturing. It has recently explored BCI applications in intelligent driving. Its main business includes automotive-grade chips, power semiconductors, and semiconductor packaging and testing, serving automotive electronics and industrial control sectors, while promoting R&D for BCI in intelligent driving scenarios. It is investigating the use of BCI in intelligent driving, enabling vehicle control through mind-control technology, opening new possibilities for automotive intelligence. As human-machine interaction demands in intelligent driving increase, the application potential of BCI in the automotive field is expected to be realized. The company may use its chip technology advantages to seize market opportunities.

Zhongke Information (300678), backed by Chinese Academy of Sciences technology, has deep积累 in intelligent monitoring and industrial inspection. It has recently focused on BCI applications in industrial settings. Its main business includes intelligent monitoring systems, industrial inspection equipment, and information solutions, serving energy, manufacturing, and government sectors, while advancing R&D for BCI in industrial monitoring. It focuses on applying BCI in industrial inspection and intelligent monitoring, using EEG signals for equipment status monitoring and fault预警, expanding industrial applications. As monitoring precision demands in industrial intelligence increase, BCI applications in the industrial field are expected to accelerate. The company may leverage its technical积累 to launch mind-controlled monitoring products, enhancing industrial production efficiency.

Pony Testing (300887), a leading third-party inspection agency in China, holds authoritative qualifications in testing areas like biocompatibility and electromagnetic compatibility, providing compliance testing services for BCI devices. Its main business includes third-party testing, certification, and technical consulting services, covering medical, electronic, and food sectors, while offering biocompatibility and EMC testing for BCI equipment. It provides third-party testing services such as biocompatibility and electromagnetic compatibility for BCI devices, ensuring product compliance and safety, positioning it as a key midstream service provider. As BCI industry regulations improve, testing demand is expected to grow steadily. The company can leverage its authoritative qualifications to deepen collaborations with BCI enterprises, supporting the industry's healthy development.

Plastic (002324) specializes in the R&D and production of polymer materials, with technical advantages in flexible materials and encapsulation materials, providing core material support for BCI devices. Its main business involves the R&D, production, and sales of polymer materials, composite materials, and modified plastics, covering automotive, electronic, and medical sectors, while supplying flexible encapsulation materials for BCI equipment. It provides flexible encapsulation materials for BCI devices, improving their durability and biocompatibility, establishing it as an upstream material supplier. As demand for flexible materials in BCI devices increases, orders for encapsulation materials are expected to grow. The company can deepen collaborations with BCI firms using its material technology advantages, supporting the industry's scaled development.

Tianqi Co., Ltd. (002009) is involved in intelligent equipment manufacturing and industrial automation, with experience in robot control and intelligent manufacturing. It has recently explored BCI applications in industrial robots. Its main business includes intelligent equipment, industrial robots, and automated production lines, serving automotive, new energy, and manufacturing sectors, while promoting R&D for BCI in industrial control. It is investigating the use of BCI in industrial robots, enabling precise robot control through mind-control technology, opening new possibilities for intelligent manufacturing scenarios. As control precision demands in industrial intelligence increase, BCI applications in the industrial field are expected to accelerate. The company may leverage its equipment manufacturing advantages to launch mind-controlled robot products, enhancing industrial production efficiency.

Chengyitong (300430) has deep experience in pharmaceutical intelligent manufacturing and rehabilitation equipment, with expertise in rehabilitation training and medical device R&D. It has recently explored BCI applications in rehabilitation scenarios. Its main business includes pharmaceutical intelligent manufacturing equipment, rehabilitation training devices, and medical information solutions, serving pharmaceutical and medical sectors, while promoting R&D for BCI in rehabilitation training. It is investigating the use of BCI in rehabilitation training, optimizing rehabilitation plans through mind-control technology to achieve precise training and improve rehabilitation efficiency. With growing demand for neurological rehabilitation, BCI applications in medical settings are expected to accelerate. The company may leverage its technical积累 to launch mind-controlled rehabilitation products, expanding the boundaries of medical services.

Haige Communication (002465), a core enterprise in domestic military communication and navigation, has technical advantages in specialized communication and data transmission. It has recently provided support for BCI in specialized scenarios. Its main business includes military communication equipment, navigation systems, and information solutions, serving defense and government sectors, while supplying military communication components for BCI devices. It provides military communication and data transmission solutions for BCI equipment, supporting brain-computer interaction in specialized scenarios, positioning it as a key midstream supplier. As demand for brain-computer interaction in specialized scenarios increases, demand for communication equipment is expected to grow. The company can leverage its technical strengths to deepen collaborations with BCI enterprises, expanding applications in defense and emergency response scenarios.

Nanjing Panda (600775) leverages its expertise in electronic manufacturing and communication technology, with deep积累 in intelligent terminals and information systems. It has recently focused on BCI applications in smart terminals. Its main business includes electronic manufacturing, communication equipment, and smart terminal products, serving consumer electronics and government sectors, while promoting R&D for BCI in smart terminals. Building on its electronic manufacturing and communication technology, it is developing BCI applications in smart terminals, enabling device control through mind-control technology, opening new possibilities in consumer electronics scenarios. As interaction method demands for smart terminals evolve, the application potential of BCI in the consumer electronics field is expected to be realized. The company may use its manufacturing advantages to seize market opportunities.

Taihe Technology (300801) specializes in fine chemicals and water treatment materials, with technical advantages in biocompatible coating materials, providing core material support for BCI devices. Its main business includes fine chemical products, water treatment materials, and functional chemicals, covering industrial, medical, and environmental protection sectors, while supplying biocompatible coating materials for BCI equipment. It provides biocompatible coating materials for BCI devices, enhancing their safety and durability, establishing it as an upstream material supplier. As biocompatibility requirements for BCI devices increase, orders for coating materials are expected to grow. The company can deepen collaborations with BCI firms using its material technology advantages, supporting the industry's scaled development.

Lepu Medical (300003) has extensive experience in cardiovascular and neurointervention, with substantial expertise in medical device R&D and clinical applications. It has recently explored BCI applications in cardiac rehabilitation and neuromodulation. Its main business includes cardiovascular intervention products, neurointervention devices, and medical services, covering cardiovascular and neurological fields, while promoting the implementation of BCI in rehabilitation scenarios. It is investigating the use of BCI in cardiac rehabilitation and neuromodulation, optimizing treatment plans through BCI technology to achieve precise rehabilitation training and improve efficiency. With growing demand for cardiovascular and neurological rehabilitation, BCI applications in medical settings are expected to accelerate. The company may leverage its technical积累 to launch mind-controlled rehabilitation products, expanding the boundaries of medical services.

Yahua Electronic (301337) focuses on medical informatization and intelligent nursing equipment, with experience in patient monitoring and improving medical service efficiency. It has recently explored BCI applications in intelligent nursing. Its main business includes medical information systems, intelligent nursing equipment, and patient monitoring solutions, serving hospitals and elderly care institutions, while promoting R&D for BCI in patient monitoring. It is investigating the use of BCI in intelligent nursing and patient monitoring, using EEG signals for real-time patient status monitoring to enhance medical service efficiency. As demands for precise monitoring in medical services increase, BCI applications in medical settings are expected to accelerate. The company may leverage its technical积累 to launch mind-controlled monitoring products, improving the quality of medical services.

The above content is compiled solely from public information and does not constitute any investment advice. It is for reference only.